08 December 2020
Visiongain has published a new report on Track and Trace Solutions Market Report 2021-2031: Forecasts by Product (Plant Manager, Checkweighers, Barcode Scanner, Verification) Technology (2D Barcode, RFID) Application (Serialization, Aggregations, Reporting), End User (Pharmaceutical, Medical Devices). PLUS Profiles of Leading Track and Trace Product Manufacturing Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios.
Global Track and Trace Solutions market was valued at US$ xx billion in 2020 and is projected to reach at a market value of US$ xx billion by 2031. The key factors driving the growth of this market include the severe regulations & principles for the implementation of serialization, increasing focus of manufacturers on brand protection, growth in the number of packaging-related product recalls, and growth in the medical device industry.
COVID-19 Impact on Track and Trace Solutions Market
The spread of COViD-19 pandemic has affected many industries globally. The track and trace market is predicted to boost during the forecast period owing to the need of tracking of COViD-19 patients at every hour at each corner of the globe. Thus, the track and trace solutions market will have a positive impact for its growth during the spread of pandemic.
Growth in the medical device industry is driving the growth of the track and trace solutions market. The medical and pharmaceutical industry are adopting the tracking and tracing devices in order to be aware about the spread of novel diseases along with the data of patients who are getting in contact of the disease. The medical and hospital industry is also utilizing the advancement in technology provided by the track and trace solutions.
Remote authentication of products is increasing which is utilizing the tracking and tracing devices. Thus the industry involved in remote tracking and authenticating of medical and pharmaceutical devices are offering wide growth prospects for the track and trace solutions market.
Some of the companies profiled in the report include OPTEL Group (Canada), Mettler-Toledo International Inc. (US), Systech International Inc. (US), TraceLink Inc. (US), Antares Vision (Italy), Xyntek Inc. (US), Adents International (France), SEA Vision Srl (Italy), Robert Bosch (Germany), Körber Medipak Systems AG (Switzerland), Siemens AG (Germany), Uhlmann Group (Germany), Zebra Technologies Corporation (US), Axway Inc. (US), and ACG Worldwide (India)
• In 2018, Antares Vision introduced its product, ATSFOUR, an enterprise-level serialization software solution. The new ATSFOUR assimilates the Antares Tracking System architecture and offers a wide-ranging solution which allows the widest connection capability for any traceability network.
• In 2018, Ropack Pharma Solutions (Canada) signed a contract with Trace-Link (US) in order to achieve DSCSA compliance for its pharmaceutical customers.
• In 2017, OPTEL Group (Canada) bought Verify Brand LLC (US). The addition of Verify Brand’s L4/5 serialization capabilities to the OPTEL solution set enables the connectivity required for pharma companies to implement Track & Trace across the entire supply chain (L1 to L5).
• In 2017, Antares Vision joined hands with Xyntek, wherein Xyntek will continue to sell and service solutions of the Antares Tracking System platform throughout the US.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 20 7549 9987.
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The mesenchymal stem cells market was valued at US$2.44 billion in 2021 and is projected to grow at a CAGR of 13.82% during the forecast period 2022-2032.
21 September 2022
The global advanced wound care management market is estimated to be valued at US$12,581.3 million in 2022. The market is projected to reach a market value of US$23,307.5 million by 2032 and is projected to grow at a CAGR of 6.36% during the forecast period 2022-2032.
16 September 2022
The gene therapy R&D market was valued at US$1,653.0 million in 2021 and is projected to grow at a CAGR of 30.1% during the forecast period 2022-2032.
15 September 2022
The medical device contract manufacturing market was valued at US$69.22 billion in 2021 and is projected to grow at a CAGR of 12.9% during the forecast period 2022-2032.